GlassScriptPhysician profile
David Preston Johnson
NPI 1134530926
$13,589.77
in general payments reported to CMS, 2019-2025
53 companies · $1,825 in 2025
The $1,825 reported for 2025 was more than what 78% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,842 · 2020: $1,313 · 2021: $2,102 · 2022: $2,308 · 2023: $3,185 · 2024: $1,015 · 2025: $1,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,413 · Travel and Lodging: $1,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,413.06 |
| Travel and Lodging | $1,612.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,864.04 | 2019-2025 | Octrode, Proclaim, Eterna |
| Medtronic, INC. | $1,500.09 | 2023-2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Intellis Adaptivestim |
| Nevro Corp. | $1,210.83 | 2019-2024 | Senza |
| Abbvie INC. | $1,135.76 | 2021-2025 | |
| Si-Bone, INC. | $484.91 | 2023-2025 | |
| Stryker Corporation | $479.90 | 2025 | Mild Device Kit |
| Medtronic USA, INC. | $426.19 | 2019-2020 | |
| Boston Scientific Corporation | $322.89 | 2020-2025 | Na, Superion Indirect Decompression System, General - Pain Management |
| Amgen INC. | $316.40 | 2020-2025 | Krystexxa, Aimovig |
| Collegium Pharmaceutical, INC. | $259.82 | 2021-2024 | Belbuca, Xtampza |
| Lundbeck LLC | $253.56 | 2021-2023 | Vyepti |
| Scilex Pharmaceuticals INC. | $241.32 | 2019-2025 | Ztlido |
| Spinal Simplicity, LLC | $163.43 | 2023-2024 | Ha Minuteman G3-R |
| Grifols USA, LLC | $150.45 | 2022-2023 | Gamunex-C, Xembify |
| Biohaven Pharmaceuticals, INC. | $121.51 | 2020-2021 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.